The ADAM9 gene, which stands for A Disintegrin And Metalloproteinase 9, encodes a member of the ADAM family of proteins, which are involved in various biological processes such as cell adhesion, migration, and signaling. ADAM9 is a multi-domain protein that includes a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type I motif. This protein is known to cleave several cell surface molecules, thereby affecting cell-cell interactions and the extracellular matrix.Research has shown that ADAM9 is implicated in a range of physiological and pathological conditions. In cancer, ADAM9 has been found to be overexpressed in various types of tumors, where it promotes tumor growth, invasion, and metastasis by facilitating the shedding of cell surface receptors and modifying the tumor microenvironment. Additionally, ADAM9 has been associated with cardiovascular diseases, where it contributes to angiogenesis and plaque instability.